Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Oklahoma
With
Midwest Medical Isotopes
The first primary objective reflects a necessary and preliminary requirement: to reproduce published results and validate the use of FLT-PET. In this study, 35 patients will be selected to undergoing imaging with both FLT and FDG PET.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18 years or older
Women must not be pregnant or breast feeding
Histologic diagnosis of non-Hodgkin's lymphoma (any stage)
Must undergo treatment with chemotherapy and/or radiotherapy
You may not be if
May not have received previous therapy with radiopharmaceuticals
May not have received prior therapy with cytotoxic chemotherapy and/or monoclonal antibodies
Clareo Health | Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
